Related Experiment Videos

[Purulent meningitis at the Marselisborg Hospital 1980-1990]

B Hansen1, F T Black, P L Andersen

  • 1Medicinsk-epidemisk afdeling A., Marselisborg Hospital, Arhus.

Ugeskrift for Laeger
|November 21, 1994
PubMed

Insights

High-dose penicillin monotherapy remains effective for treating bacterial meningitis, including meningococcal and pneumococcal infections, with low mortality and sequelae rates in immunocompetent patients. Amplicillin is effective for Haemophilus influenzae meningitis.

Area of Science:

  • Infectious Diseases
  • Clinical Microbiology
  • Bacteriology

Context:

  • Retrospective analysis of 245 immunocompetent patients admitted between 1980-1990 with purulent meningitis or meningococcal septicaemia.
  • Diagnosis confirmed by clinical examination, neutrophil pleocytosis, and bacterial identification in cerebrospinal fluid or blood cultures.
  • Meningococcal disease diagnosed by clinical signs of disseminated intravascular coagulation (DIC) or positive meningococcal antibody test (MAT).

Purpose:

  • To evaluate the clinical outcomes and treatment efficacy of bacterial meningitis and meningococcal septicaemia in immunocompetent patients.
  • To assess the mortality and sequelae rates associated with different causative agents and treatment regimens.
  • To determine the continued value of betalactam antibiotic monotherapy for meningitis in Denmark.

Summary:

  • Meningococcal disease (45%), pneumococcal meningitis (28%), and H. influenzae meningitis (8%) were the primary causes. Mortality rates were 5.4% for meningococcal, 13% for pneumococcal, and 0% for H. influenzae meningitis.
  • Sequelae rates were 17% for meningococcal, 17% for pneumococcal, and 5% for H. influenzae meningitis.
  • High-dose penicillin monotherapy was used for meningococcal and pneumococcal meningitis, while ampicillin was used for H. influenzae meningitis and in children under five with unknown aetiology. No ampicillin-resistant H. influenzae strains were found.

Impact:

  • Betalactam antibiotic monotherapy demonstrates continued value in treating bacterial meningitis, offering favorable outcomes.
  • The study provides evidence supporting current treatment guidelines for bacterial meningitis in immunocompetent populations.
  • Findings contribute to understanding the epidemiology and treatment effectiveness of common meningitis causes.

Related Concept Videos